Nutraceuticals Market to Hit USD 658.11 Billion by 2028 | Nutraceuticals Industry CAGR 9.3% During 2021-2028; Fortune Business Insights™

NEXT STORY
Molecular Partners Confirms Retained Activity of Ensovibep on the Positions Mutated in Emerging Omicron Variant of SARS-CoV-2 In Vitro
PREV STORY
Junshi Biosciences Announces Approval of Supplemental New Drug Application by NMPA for Toripalimab in Combination with Cisplatin and Gemcitabine as First-Line Treatment for Patients with Locally Recurrent or Metastatic Nasopharyngeal Carcinoma
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect Announces Presentation of New Data from its Amurin Peptide Program at the ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance

author_avatar
NASDAQ Market News

Valneva Reports H1 2021 Financial Results and Provides Business Update

author_avatar
NASDAQ Market News

MacroGenics Presents Updated Data from Phase 1 Study of MGD010 at Annual European Congress of Rheumatology (EULAR 2017)

ROCKVILLE, MD, June 17, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage ...

author_avatar
NASDAQ Market News